Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleSafety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsSeung Hyun Kim